Launched Dacarb (Dacarbazine) 200mg, 500mg strength

Launched Dacarb (Dacarbazine)

Launched Dacarbazine in 2019 by the brand name Dacarb 200mg, 500mg strength

Approved indications of Dacarb

  • Treatment of metastatic malignant melanoma.
  • Indicated for Hodgkin’s disease as a second- line therapy when used in combination with other effective agents..